Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 1,087.87 million compared to INR 1,936.02 million a year ago. Revenue was INR 1,103.2 million compared to INR 1,950.15 million a year ago. Net income was INR 15.09 million compared to INR 29.19 million a year ago. Basic earnings per share from continuing operations was INR 0.59 compared to INR 1.15 a year ago. Diluted earnings per share from continuing operations was INR 0.59 compared to INR 1.15 a year ago.